Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Danzhufuyuan Prescription is a traditional Chinese medicine (TCM) formula, commonly prepared as granules. It is used primarily for the treatment of syndromes characterized by intermingle phlegm and blood stasis, according to TCM theory. The prescription typically contains a combination of herbal ingredients such as Dan Zhu Ye (Lophatherum gracile), Fu Ling (Poria cocos), and other botanicals, though exact composition may vary by manufacturer or clinical protocol. Its mechanism of action is based on TCM principles—promoting blood circulation, resolving phlegm, and harmonizing internal organ function—rather than targeting specific molecular pathways recognized in Western pharmacology. Clinical studies have evaluated its effectiveness and safety in patients with these TCM-defined syndromes[7]. There is no evidence that it has been developed or approved as a pharmaceutical drug outside the context of traditional medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Danzhufuyuan Prescription.